Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu

Updated on: December 25,2023

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu

Updated on:December 25,2023

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit

Updated on: June 01,2024

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit

Updated on:June 01,2024

Researchers develop new open-source method to improve decoding of single-cell data

by Ian Demsky,Memorial Sloan Kettering Cancer CenterSpectra uses gene sets and cell types to guide gene program discovery from scRNA-seq data.a, As input, Spectra receives a gene expressio

Updated on: June 11,2024

Researchers develop new open-source method to improve decoding of single-cell data

by Ian Demsky,Memorial Sloan Kettering Cancer CenterSpectra uses gene sets and cell types to guide gene program discovery from scRNA-seq data.a, As input, Spectra receives a gene expressio

Updated on:June 11,2024

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re

Updated on: January 22,2024

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re

Updated on:January 22,2024

Researchers map the effects of all potential changes in key cancer gene

byThe Francis Crick InstituteFunction scores capture fitness effects mediated at both the transcript and protein 457 level. Credit: Megan Buckley et alResearchers at the Francis Crick Institute

Updated on: July 06,2024

Researchers map the effects of all potential changes in key cancer gene

byThe Francis Crick InstituteFunction scores capture fitness effects mediated at both the transcript and protein 457 level. Credit: Megan Buckley et alResearchers at the Francis Crick Institute

Updated on:July 06,2024

Researchers translate a hypothesis into a personalized treatment for cancer

byUniversity of CalgaryFranz Zemp designed a personalized CAR T-cell therapy for a Calgary teen. Credit: Arnie Charbonneau Cancer Institute, University of CalgaryDr. Franz Zemp, Ph.D., gets chil

Updated on: January 26,2024

Researchers translate a hypothesis into a personalized treatment for cancer

byUniversity of CalgaryFranz Zemp designed a personalized CAR T-cell therapy for a Calgary teen. Credit: Arnie Charbonneau Cancer Institute, University of CalgaryDr. Franz Zemp, Ph.D., gets chil

Updated on:January 26,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204

Updated on: January 30,2024

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204

Updated on:January 30,2024

New health mapping study pinpoints cancer risk factors at local level

byQueensland University of TechnologyThe maps show areas where unhealthy behaviors are more (marked in red) or less (in blue) common than the national average. The deeper the shade, the greater

Updated on: December 28,2023

New health mapping study pinpoints cancer risk factors at local level

byQueensland University of TechnologyThe maps show areas where unhealthy behaviors are more (marked in red) or less (in blue) common than the national average. The deeper the shade, the greater

Updated on:December 28,2023

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on: March 25,2024

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on:March 25,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on: January 04,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on:January 04,2024

What is the breast cancer risk calculator recommended by Olivia Munn?

by Carla K. JohnsonOlivia Munn arrives at the Governors Awards on Tuesday, Jan. 9, 2024, at the Dolby Ballroom in Los Angeles. When Munn revealed in March 2024 that she was diagnosed with breast cance

Updated on: March 20,2024

What is the breast cancer risk calculator recommended by Olivia Munn?

by Carla K. JohnsonOlivia Munn arrives at the Governors Awards on Tuesday, Jan. 9, 2024, at the Dolby Ballroom in Los Angeles. When Munn revealed in March 2024 that she was diagnosed with breast cance

Updated on:March 20,2024